Glycyrrhetinic acid and related compounds induce G1 arrest and apoptosis in human hepatocellular carcinoma HepG2

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4043-4047

  Satomi, Yoshiko ^a   Nishino, Hoyoku ^a   Shibata, Shoji ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b Minophagen Pharmaceutical Co   (Japan)

Author keywords

Apoptosis; Bcl 2 family; G1 arrest; Glycyrrhetinic acid; Glycyrrhizin; Hepatocellular carcinoma

Indexed keywords

18BETA OLEAN 12 ENE 3BETA,23,28 TRIOL; ANTINEOPLASTIC AGENT; CASPASE 8; CASPASE 9; CONNEXIN 32; DNA; GAP JUNCTION PROTEIN; GLYCYRRHETINIC ACID; OLEANOLIC ACID; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; UNCLASSIFIED DRUG; URSOLIC ACID;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; FLOW CYTOMETRY; GAP JUNCTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CASPASE 8; CASPASE 9; CASPASES; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CONNEXINS; ENZYME ACTIVATION; FLOW CYTOMETRY; G1 PHASE; GLYCYRRHETINIC ACID; HUMANS; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TRITERPENES;

EID: 27944489889     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota K, Koida I, Suzuki Y, Saitoh S, Kobayashi M and Kumada H: The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer 79: 1494-1500, 1997.
2. Shiota G, Harada K, Ishida M, Tomie S, Okubo M, Katayama S, Ito H and Kawasaki H: Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrsoamine-treated mice. Carcinogenesis 20: 59-63, 1999.
3. Abe H, Ohya N, Fujikawa-Yamamoto K, Shibuya T, Arichi S and Odashima S: Effects of glycyrrhizin and glycyrrhetinic acid on growth and melanogenesis in cultured B16 melanoma cells. Eur J Cancer Clin Oncol 23: 1549-1555, 1987.
4. Rossi T, Castelli M, Zandomeneghi G, Ruberto A, Benassi L, Magnoni C, Santachiara S and Baggio G: Selectivity of action of glycyrrhizin derivatives on the growth of MCF-7 and HEP-2 cells. Anticancer Res 23: 3813-3818, 2003.
5. Sasaki H, Takei M, Kobayashi M, Pollard RB and Suzuki F: Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients. Pathobiology 70: 229-236, 2003.
6. Abe N, Ebina T and Ishida N: Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. Microbiol Immunol 26: 535-539, 1982.
7. Dai JH, Iwatani Y, Ishida T, Terunuma H, Kasai H, Iwakula Y, Fujiwara H and Ito M: Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages. Immunology 103: 235-243, 2001.
8. Nishino H, Yoshioka K, Iwashima A, Takizawa H, Konishi S, Okamoto H, Okabe H, Shibata S and Fujiki H: Glycyrrhetinic acid inhibits tumor-promoting activity of teleocidin and 12-O-tetradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis. Cancer Sci (Jpn J Cancer Res) 77: 33-38, 1986.
9. Nishino H, Nishino A, Takayasu J, Hasegawa T, Iwashima A, Hirabayashi K, Iwata S and Shibata S: Inhibition of the tumor-promoting action of 12-O-tetradecanoylphorbol-13-acetate by some oleanane-type triterpenoid compounds. Cancer Res 48: 5210-5215, 1988.
10. Davidson JS, Baumgarten IM and Harley EH: Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. Biochem Biophys Res Commun 134: 29-36, 1986.
11. Davidson JS and Baumgarten IM: Glycyrrhetinic acid derivatives: a novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships. J Pharm Exp Ther 246: 1104-1107, 1988.
12. Guan X, Wilson S, Schlender KK and Ruch RJ: Gap-junction disassembly and connexin 43 dephosphorylation induced by 18β-glycyrrhetinic acid. Mol Carcinogenesis 16: 157-164, 1996.
13. Kirkin V, Joos S and Zörnig M: The role of Bcl-2 family members in tumorigenesis. Biochem Biophys Acta 1644: 229-249, 2004.
14. Cory S, Huang DCS and Adams JM: The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22: 8590-8607, 2003.
15. Horigome H, Homma M, Hirano T and Oka K: Glycyrrhetinic acid induced apoptosis in murine splenocytes. Biol Pharm Bull 24: 54-58, 2001.
16. Salvi M, Fiore C, Armanini D and Toninello A: Glycyrrhetinic acid-induced permeability transition in rat liver mitochondria. Biochem Pharm 66: 2375-2379, 2003.
17. Kao ST, Yeh CC, Hsieh CC, Yang MD, Lee MR, Liu HS and Lin JG: The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest. Life Sci 69: 1485-1496, 2001.
18. Nishida S, Kikuchi S, Yoshioka S, Tsubaki M, Fujii Y, Matsuda H, Kubo M and Irimajiri K: Induction of apoptosis in HL-60 cells treated with medicinal herbs. Am J Chinese Med 31: 551-562, 2003.
19. Evans WH and Martin PEM: Gap junctions: structure and function (Review). Mol Membr Biol 19: 121-136, 2002.
20. Yamasaki H: Gap junctional intercellular communication and carcinogenesis. Carcinogenesis 11: 1051-1058, 1990.
21. Shiozaki EN and Shi Y: Caspases, IAPs and Smac/DIABLO: mechanisms from structural biology. TRENDS Biochem Sci 39: 486-494, 2004.